My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
27.37
+0.29 (+1.07%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
CoreWeave's Sudden Plunge: A Reality Check for the High-Flying AI Infrastructure Market
September 30, 2025
Today's market close saw an unexpected and significant downturn for CoreWeave (NASDAQ: CRWV), the specialized AI cloud provider, marking it as one of the day's bottom performers. This abrupt reversal...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Trump Announces Pfizer Drug-Pricing Deal, Company To Invest $70 Billion in US Manufacturing
September 30, 2025
Via
Stocktwits
Topics
Government
Pfizer Plummets as Key Obesity Drug Candidate Faces Major Setback, Shaking Investor Confidence
September 30, 2025
New York, NY – September 30, 2025 – Shares of pharmaceutical giant Pfizer (NYSE: PFE) experienced a dramatic decline today, making it one of the market's bottom performers, following an unexpected and...
Via
MarketMinute
Topics
Intellectual Property
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
September 30, 2025
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a...
Via
MarketMinute
Topics
Government
Agilent (A) Soars as White House-Pfizer Drug-Pricing Agreement Signals New Era for Pharma
September 30, 2025
Washington D.C. – September 30, 2025 – Shares of Agilent Technologies (NYSE: A) experienced a significant upward movement today, closing strong amidst breaking news of a landmark drug-pricing agreement...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
September 30, 2025
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing...
Via
MarketMinute
Topics
Economy
Government
World Trade
Pharmaceutical Pricing Shake-Up Casts Long Shadow on Biotech Suppliers, Bruker Navigates Headwinds Amidst Market Volatility
September 30, 2025
As of September 30, 2025, the financial markets are grappling with the implications of a landmark drug-pricing agreement between the White House and pharmaceutical giant Pfizer (NYSE: PFE), a move...
Via
MarketMinute
Topics
Economy
Government
Supply Chain
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
September 30, 2025
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
Via
StockStory
Topics
Government
Why Are Eli Lilly (LLY) Shares Soaring Today
September 30, 2025
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 5.5% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the...
Via
StockStory
Topics
Government
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
September 30, 2025
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
Via
StockStory
Topics
Government
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know
September 30, 2025
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...
Via
StockStory
Topics
Government
World Trade
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know
September 30, 2025
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
Via
StockStory
Topics
Government
Bio-Techne (TECH) Shares Skyrocket, What You Need To Know
September 30, 2025
Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 5.3% in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical...
Via
StockStory
Topics
Government
What's going on in today's session: S&P500 movers
September 30, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Why Pfizer (PFE) Stock Is Trading Up Today
September 30, 2025
Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 5.9% in the afternoon session after the company reached an agreement with the U.S. government to lower drug prices and reported positive...
Via
StockStory
Topics
Death
‘TrumpRx’ Deal With Pfizer To Offer Discount Drugs Direct To Consumers
September 30, 2025
TrumpRx would allow people to buy drugs directly from a government website, at a discounted price negotiated by the government.
Via
Talk Markets
Pfizer Becomes First Drugmaker To Join Trump's Price Cut Push
September 30, 2025
Pfizer and the Trump Administration have reached a landmark agreement to lower U.S. prescription drug prices.
Via
Benzinga
Topics
Government
Curious about the most active S&P500 stocks in today's session?
September 30, 2025
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market...
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
September 30, 2025
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Via
Chartmill
Unusual volume S&P500 stocks in Tuesday's session
September 30, 2025
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
Via
Chartmill
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
September 30, 2025
From
Pfizer Inc.
Via
Business Wire
Discover which S&P500 stocks are making waves on Tuesday.
September 30, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
Pfizer Shares Gain Amid Reports Of Deal With The US Government
September 30, 2025
Pfizer stock climbed over 3% on news of an impending drug-pricing deal with the Trump administration.
Via
Talk Markets
Topics
Government
Why Pfizer Stock Just Popped
September 30, 2025
Bowing to pressure from Washington, the company is preparing to announce price cuts on drugs for U.S. customers.
Via
The Motley Fool
Topics
Government
Pfizer Shares Are Trading Higher Tuesday: What's Going On?
September 30, 2025
Pfizer, Inc. (NYSE:PFE) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump will announce a drug-pricing deal with the company.
Via
Benzinga
Topics
Government
Trump To Announce Drug-Pricing Pact With Pfizer Later Today: Report
September 30, 2025
According to a report by The Washington Post, the deal would require Pfizer to voluntarily offer its medications through Medicaid at reduced prices.
Via
Stocktwits
Topics
Government
Wall Street Defies D.C. Drama: Strong Gains Persist Amidst Looming Government Shutdown
September 30, 2025
As the clock ticks towards the critical September 30, 2025, fiscal year-end deadline, Washington D.C. finds itself embroiled in familiar budget battles, once again raising the specter of a U.S....
Via
MarketMinute
Topics
Economy
Regulatory Compliance
Stocks
US Government Shutdown Looms: Market Braces for Impact on S&P 500, Dow, and Nasdaq
September 30, 2025
As of late September 2025, the specter of a US government shutdown casts a long shadow over financial markets, prompting an immediate atmosphere of caution and uncertainty. With the fiscal year-end...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Global Trade Tensions Unleash Volatility in Stock Futures: A Deep Dive into Tariff-Driven Market Ripples
September 30, 2025
The global financial markets are currently navigating a tumultuous period, largely driven by an escalating wave of new trade tariffs. As of September 30, 2025, a series of aggressive trade policy...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.